share print

Our strategy

From the beginning, HRA Pharma has dared to put innovation at the center of its model for growth. We have worked closely with a network of talented partners to bring a range of treatments and services to market, in areas of otherwise unmet medical needs - with over 10 products launched to date and 8 in the pipeline.

We have dared to promote and develop a sustainable growth strategy, in pursuit of our dream to meet healthcare challenges in the areas of women’s health and endocrinology. We flourish by sharing our vision with partners to continuously nourish our ever-expanding product portfolio.
Our skill in searching out the best science and the finest companies to partner with means we continue to grow our portfolio of truly innovative products and continue to share the clinical benefits of our treatments with patients all over the world.
Our fast-growing geographical footprint supports our ambition to capitalize on our European market knowledge and develop our structure to adapt to future challenges and opportunities worldwide.

The secret of our success

We have proven scientific ability driven by a highly experienced management team, with in-depth knowledge of clinicians’ needs; first-hand knowledge of specific regulatory contexts around the world; and extensive experience in product lifecycle management. Our focus on women’s health and endocrinology enables us to develop the most innovative treatments on the market. Our innovations are supported by a dynamic sales and marketing team and our product pipeline enables us to constantly evaluate innovative technologies and approaches, such as cell therapy and muscle regeneration, in order to bring new products to market. Our talented research and innovation teams are instrumental in driving projects through pre-clinical to clinical trials stage.


closeyou are leaving hra pharma
You are now leaving and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?